Neil Abdollahian's Insider Trades & SAST Disclosures
Neil Abdollahian's most recent trade in Boundless Bio Inc. was a trade of 82,051 Stock Option done . Disclosure was reported to the exchange on Aug. 19, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Neil Abdollahian.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 82,051 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 82,051 | 82,051 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 54,871 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 54,871 | 54,871 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 36,852 | 36,852 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 36,852 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 23,191 | 23,191 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 23,191 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2024 | 19,948 | 0 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 19,948 | 19,948 | - | - | Stock Option | |
| Boundless Bio Inc. | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 23,191 | 23,191 | - | - | Stock Option | |
| Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 3,500 | 58,940 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.06 per share. | 05 Jan 2021 | 2,868 | 55,440 (0%) | 0% | 2.1 | 5,908 | Common Stock |
| Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 2.66 per share. | 05 Jan 2021 | 1,469 | 57,471 (0%) | 0% | 2.7 | 3,908 | Common Stock |
| Cidara Therapeutics Inc | Neil Abdollahian | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 115,000 | 115,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges